Higher numbers of Th17 cells, IL-17-secreting CD8+ T cells and IL-17A in patients with NMO in comparison with those with MS suggest that inflammation and demyelination is more severe in NMO than in MS [18]. Here, IL17A is linked to myeloid sarcoma.